CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE
Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin- 3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
17.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin- 3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof. |
---|---|
AbstractList | Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin- 3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof. |
Author | EIDAM, HILARY SCHENCK LAMEY, KIMBERLY ANNE CHEUNG, MUI CLARK, WILLIAM M THOMAS, JAMES V |
Author_xml | – fullname: EIDAM, HILARY SCHENCK – fullname: LAMEY, KIMBERLY ANNE – fullname: THOMAS, JAMES V – fullname: CHEUNG, MUI – fullname: CLARK, WILLIAM M |
BookMark | eNqNjM0KgzAQhD20h_69g0cLLtRf6DFoxEDMSkzB9CJS0lNRwT5KH7gR-wBlB5aZ-Zi9sxnGweycTyZ1owjnTFC3QFk1LhZuCF68iKoSWw0pYIsQ-CnkrNS5xFpLljMBEWh-hhAKfkObllQsXoCXgBf49kBJtpaWquyc5rUFibDWoqzBltyRr0Mko4pULKdHZ_vsX7M5_f7BcQuqshLMNHZmnvqHGcy7y0h4TS9xEpAg-gP5AlkAQTs |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | FORMES CRISTALLINES DE 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE |
ExternalDocumentID | CA2960451A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2960451A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:57:46 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2960451A13 |
Notes | Application Number: CA20152960451 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160317&DB=EPODOC&CC=CA&NR=2960451A1 |
ParticipantIDs | epo_espacenet_CA2960451A1 |
PublicationCentury | 2000 |
PublicationDate | 20160317 |
PublicationDateYYYYMMDD | 2016-03-17 |
PublicationDate_xml | – month: 03 year: 2016 text: 20160317 day: 17 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED |
RelatedCompanies_xml | – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED |
Score | 3.0248969 |
Snippet | Disclosed are novel crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160317&DB=EPODOC&locale=&CC=CA&NR=2960451A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMAwV9U2n4vyiDzImLNhuTbI-DOnSllbWZnSdtL6Mrquwl264iX_EH-yl-9AXJXnI5Y6DXLhcLsldELpXM5UZRsow7agE61lKsEFkIsg8VadsmlGmynhnP6DuSH-OSVxBs20sTJkn9LNMjggalYG-r8r1evFziGWVbyuXj5MZdM2fnKhr1TfecflnMqtbva49EJbgdc673KwHYbclk5AQzQRHaR920Uwqg_3Sk0Epi98WxTlBBwNgVqxOUSUvquiIbz9eq6JDf3PfDc2N6i3P0BcPk2Fkgu8d2Aq4bv5QEY7Swg1dVjtyRZxgikUssNak2PLcxArFIAk9ywtwGyf9B9zCTn8koNe1AwkHuEFwQ2tCwVHorZFA5QO7pD8AQjMAEEi9oYjNV9FfMzK5HZm-Z9nnSHHsiLsYhjfeiXLMzZ0g2hdor5gX-SVSGElpO88zSlOi50w3pqn-puuZRnNi0E5aQ7U_2Vz9g7tGx3JO5JMtjd2gvdX7R34LNnw1uSul_w02xpOC |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMAwV9U2n4vzsg4wJC7Zbk6wPQ7q0pdW2GV0nrS-j6yrsZYqb-Ef8wV66D31RkofcBwe5cEkuyV0QulFzlRlGxjDtqATreUawQWQiyCJTJ2ySU6bKeOcgpO5Qf0hIUkHTdSxMmSf0s0yOCBaVg70vyvn67ecQyyrfVs7vxlNAvd47cdeqr7zj8s9kVrd6XbsvLMHrnHe5WQ-jbksmISGaCY7SNuywmTQG-6kng1Lefq8ozgHa6YOw2eIQVYpZFe3x9cdrVbQbrO67obkyvfkR-uJROohN8L1DWwHXLRgowlFauKHLaseuSFJMsUgE1poUW56bWpHop5FneSFu49S_xS3s-EMBWNcOJRziBsENrQkFx5G3JAJXAOJSvw-MZgggsHoDkZjPwl8KMrkdm4Fn2cdIceyYuxi6N9qocsTNjSLaJ2hr9jorTpHCSEbbRZFTmhG9YLoxyfQXXc81WhCDdrIaqv0p5uwf2jXac-PAH4FmHs_Rvhwf-XxLYxdoa_H-UVzCer4YX5Uj8Q1QE5Z1 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+FORMS+OF+2-%284-%284-ETHOXY-6-OXO-1%2C6-DIHYDROPYRIDIN-3-YL%29-2-FLUOROPHENYL%29-N-%285-%281%2C1%2C1-TRIFLUORO-2-METHYLPROPAN-2-YL%29ISOXAZOL-3-YL%29ACETAMIDE&rft.inventor=EIDAM%2C+HILARY+SCHENCK&rft.inventor=LAMEY%2C+KIMBERLY+ANNE&rft.inventor=THOMAS%2C+JAMES+V&rft.inventor=CHEUNG%2C+MUI&rft.inventor=CLARK%2C+WILLIAM+M&rft.date=2016-03-17&rft.externalDBID=A1&rft.externalDocID=CA2960451A1 |